Drug Shortage Report for M-ESLON
| Report ID | 133326 |
| Drug Identification Number | 02019965 |
| Brand name | M-ESLON |
| Common or Proper name | morphine sulfate |
| Company Name | ETHYPHARM INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | Blister of 20 capsules |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-02-04 |
| Estimated end date | 2021-06-30 |
| Actual end date | 2021-06-17 |
| Shortage status | Resolved |
| Updated date | 2021-06-21 |
| Company comments | Shortage Meslon 100mg blister of 20 tablets |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1200 AVENUE MCGILL COLLEGE MONTREAL, QUEBEC CANADA H3B 4G7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-06-21 | French | Compare |
| v5 | 2021-06-21 | English | Compare |
| v4 | 2021-06-01 | French | Compare |
| v3 | 2021-06-01 | English | Compare |
| v2 | 2021-02-04 | French | Compare |
| v1 | 2021-02-04 | English | Compare |
Showing 1 to 6 of 6